OREANDA-NEWS. May 18, 2015. Amgen (NASDAQ: AMGN) today announced voting results from the Company's Annual Meeting of Stockholders, held in Westlake Village, Calif.  Approximately 89 percent of outstanding shares were represented at the meeting.

The director nominees

David Baltimore,

Frank J. Biondi, Jr.,

Robert A. Bradway, Fran?ois de Carbonnel,

Vance D. Coffman,

Robert A. Eckert,

Greg C. Garland,

Rebecca M. Henderson,

Frank C. Herringer,

Tyler Jacks,

Judith C. Pelham,

Ronald D. Sugar, and

R. Sanders Williams were each re-elected to Amgen's Board of Directors. Each director received at least 92 percent of the votes cast "For." With the re-election of all of the director nominees, Amgen currently has 13 directors.

With approximately 99 percent of the votes cast "For," stockholders ratified Ernst & Young LLP as Amgen's independent registered public accountants for the year ending Dec. 31, 2015.

Stockholders approved, on an advisory basis, the named executive officer compensation, commonly known as "Say on Pay." The non-binding proposal gives stockholders the opportunity to endorse or not endorse Amgen's executive pay programs and policies. Say on Pay received approximately 97 percent of the votes cast "For" the proposal.

The stockholder proposal regarding vote tabulation did not pass, receiving approximately 6 percent of the votes cast "For" the proposal.